Tehila Ben-Moshe
Chief Executive Officer at Biond Biologics Ltd.
Network origin in Tehila Ben-Moshe first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Biond Biologics Ltd.
 Biond Biologics Ltd. Pharmaceuticals: MajorHealth Technology Biond Biologics Ltd. engages in drug discovery and development. It offers cell-internalizing antibody platform that will enable antibody-targeting of intra-cellular immune factors. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel.
7
| Holding Company | Pharmaceuticals: Major | 7 |
cCAM Biotherapeutics Ltd.
 cCAM Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology cCAM Biotherapeutics Ltd. is a preclinical-stage company engaging in the development of immunotherapies to treat cancer. The company was founded by Silvia Noiman and Gal Markel in 2010 and is headquartered in Hod Ha'Sharon, Israel.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Tehila Ben-Moshe via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Medical Specialties | Chairman | |
| ARQULE, INC. | Pharmaceuticals: Major | Director/Board Member | |
BioMedix, Inc.
 BioMedix, Inc. Medical SpecialtiesHealth Technology BioMedix, Inc. provides equipment and services for non invasive detection of peripheral vascular disease. It provides suite of hardware, software and online services designed to cost-effectively detect peripheral arterial disease. The company was founded by Claver Bundac and Richard C. Magnuson in 1997 and is headquartered in St. Paul, MI. | Medical Specialties | Chief Executive Officer | |
| Spearhead, LLC | Chief Executive Officer | ||
| BIOSIG TECHNOLOGIES, INC. | Medical Specialties | Director/Board Member | |
| NEXIMMUNE, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of California, Davis | College/University | Corporate Officer/Principal | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| Ben-Gurion University of the Negev | College/University | Undergraduate Degree Masters Business Admin | |
| Robert Wood Johnson Medical School | College/University | Corporate Officer/Principal | |
| Weizmann Institute of Science | College/University | Doctorate Degree Doctorate Degree | |
Pontifax Management Co. Ltd.
 Pontifax Management Co. Ltd. Investment ManagersFinance Pontifax Management Co. Ltd. (Pontifax) is a venture capital firm founded in 2004 by Eliyahu Hurvitz. The firm is headquartered in Herzliya Pituach, Israel. | Investment Managers | Founder Private Equity Investor | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor | |
CollPlant Ltd.
 CollPlant Ltd. BiotechnologyHealth Technology CollPlant Ltd. specializes in the development and commercialization of medical products. It develops and commercialize tissue repair products for orthobiologics and advanced wound care markets. The company was founded by Tsafrir Feigin Yehuda and Oded Shoseyov in 2004 and is headquartered in Ness Ziona, Israel. | Biotechnology | Director/Board Member | |
| SCISPARC LTD. | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
Etubics Corp.
 Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA. | Biotechnology | Director/Board Member | |
Nutrinia Ltd.
 Nutrinia Ltd. Pharmaceuticals: MajorHealth Technology Nutrinia Ltd. develops bioactive feed supplements for infant formulas and animal feed. The firm is involved in broad intellectual property protection, industrial processes envelopment, conducting additional clinical trials and obtaining regulatory approval for the supplementation of pre-term and infant formulas with Insulin. The company was founded by Naim Shehadeh in 2003 and is headquartered in Ramat-Gan, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| Weill Cornell Medical College | College/University | Corporate Officer/Principal | |
| ERECH FINANCE CAHALACHA LTD | Medical Specialties | Director/Board Member | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Immodulon Therapeutics Ltd.
 Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Part of Lifexx SA, Immodulon Therapeutics Ltd. is a late-stage clinical biotechnology company based in Uxbridge, UK. Immodulon is developing a highly differentiated cancer immunotherapy approach that primes the patient’s own innate immune system with the aim to significantly enhance the efficacy of a broad range of anti-cancer therapies, including chemotherapy and checkpoint inhibitors. The British company is developing imm-101, a heat-killed mycobacterium obuense, as a broad-spectrum immunomodulatory agent with the potential to treat a range of difficult-to-treat tumors including those considered to be immunologically “ cold, ” such as pancreatic cancer. Immodulon's imm-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. The company is focused on developing safe and effective immunotherapy treatments. The company was founded in 2007 by Charles Akle, John L. Stanford. Gertjan Bartlema has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
| COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Director/Board Member | |
| KITE PHARMA INC | Biotechnology | Chief Executive Officer Director/Board Member | |
| Mali Health Organizing Project | Director/Board Member | ||
| METASTAT, INC. | Electrical Products | Chairman | |
| UROGEN PHARMA LTD. | Biotechnology | Director/Board Member | |
OCON Medical Ltd.
 OCON Medical Ltd. Medical/Nursing ServicesHealth Services OCON Medical Ltd. engages in the research and development of intrauterine device. Its products include Intrauterine Ball IUB and IUB SCu300. The company was founded by Ilan Baram on 2008 and is headquartered in Modiin, Israel. | Medical/Nursing Services | Chairman | |
| Fusimab Ltd. | Director/Board Member | ||
Eloxx Pharmaceuticals Ltd.
 Eloxx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Eloxx Pharmaceuticals Ltd. provides biopharmaceutical research and development services. The firm specializes in the discovery, development, and commercialization of drug compounds for the treatment of genetic diseases. It focuses on the treatment of diseases caused by nonsense mutations, including Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, and Tay-Sachs Hurler syndrome. Its focus areas encompass clinical drug development and target drugs discovery programs. The company was founded by Silvia Noiman and Shmuel Tuvia in 2013 and is headquartered in Herzliya, Israel. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Pontifax Group | Founder | ||
| Pontifax Management 2 G.P. (2007) Ltd. | Director/Board Member | ||
| BEYOND AIR, INC. | Medical Specialties | Director/Board Member | |
Trek Therapeutics PBC
 Trek Therapeutics PBC Pharmaceuticals: MajorHealth Technology Trek Therapeutics PBC is a for-profit company based in Cambridge, MA. The private company's mission is to develop medicines to treat infectious diseases and make them available to populations in need. The founders of the company, Jerome B. Zeldis and Ann D. Kwong, have collectively participated in developing seven approved antiviral drugs. The company aims to profitably develop safe, novel medicines for infectious diseases at affordable prices. Ann D. Kwong has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
Beyond Air Ltd.
 Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Biotechnology | Director/Board Member | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Founder Consultant / Advisor Founder | |
| VBI VACCINES INC. | Biotechnology | Director/Board Member | |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
N T B Pharma Ltd.
 N T B Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services N T B Pharma Ltd. provides scientific and technical research development services. The private company is based in Herzliya, Israel. | Miscellaneous Commercial Services | Director/Board Member | |
| CLARITAS PHARMACEUTICALS, INC. | Pharmaceuticals: Other | Director/Board Member | |
| Celgene Global Health | Chief Executive Officer | ||
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| ELOXX PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Founder | |
| ADVAXIS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ADICET BIO, INC. | Pharmaceuticals: Major | Founder Director of Finance/CFO | |
| AYALA PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Chairman Director/Board Member |
Statistics
International
| United States | 29 |
| Israel | 22 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 7 |
| Finance | 4 |
| Commercial Services | 4 |
| Producer Manufacturing | 2 |
Operational
| Director/Board Member | 136 |
| Chairman | 28 |
| Corporate Officer/Principal | 26 |
| Independent Dir/Board Member | 22 |
| Founder | 20 |
Most connected contacts
| Insiders | |
|---|---|
| Jerome Zeldis | 38 |
| Ran Nussbaum | 38 |
| David Sidransky | 32 |
| Moshe Arkin | 29 |
| Ronit Bendori | 20 |
| Aya Jakobovits | 16 |
| Guy Asher Harmelin | 15 |
| Anat Nursella | 12 |
| Silvia Noiman | 10 |
| Yuval Cabilly | 8 |
| Ori Shilo | 6 |
| Gal Markel | 2 |
| Yair Sapir | 2 |
- Stock Market
- Insiders
- Tehila Ben-Moshe
- Company connections
